TrialESMO open2022

Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.

A Boccaccino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.